230 related articles for article (PubMed ID: 29053105)
61. Incorporation of Biologic Response Variance Modeling Into the Clinic: Limiting Risk of Brachial Plexopathy and Other Late Effects of Breast Cancer Proton Beam Therapy.
Mutter RW; Jethwa KR; Wan Chan Tseung HS; Wick SM; Kahila MMH; Viehman JK; Shumway DA; Corbin KS; Park SS; Remmes NB; Whitaker TJ; Beltran CJ
Pract Radiat Oncol; 2020; 10(2):e71-e81. PubMed ID: 31494289
[TBL] [Abstract][Full Text] [Related]
62. Verification of a Monte Carlo dose calculation engine in proton minibeam radiotherapy in a passive scattering beamline for preclinical trials.
Guardiola C; De Marzi L; Prezado Y
Br J Radiol; 2020 Mar; 93(1107):20190578. PubMed ID: 31868523
[TBL] [Abstract][Full Text] [Related]
63. Optimizing proton minibeam radiotherapy by interlacing and heterogeneous tumor dose on the basis of calculated clonogenic cell survival.
Sammer M; Girst S; Dollinger G
Sci Rep; 2021 Feb; 11(1):3533. PubMed ID: 33574390
[TBL] [Abstract][Full Text] [Related]
64. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra.
Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998
[TBL] [Abstract][Full Text] [Related]
65. Spatially fractionated proton minibeams.
Meyer J; Eley J; Schmid TE; Combs SE; Dendale R; Prezado Y
Br J Radiol; 2019 Mar; 92(1095):20180466. PubMed ID: 30359081
[TBL] [Abstract][Full Text] [Related]
66. Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland.
Słonina D; Biesaga B; Swakoń J; Kabat D; Grzanka L; Ptaszkiewicz M; Sowa U
Radiat Environ Biophys; 2014 Nov; 53(4):745-54. PubMed ID: 25037857
[TBL] [Abstract][Full Text] [Related]
67. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
[TBL] [Abstract][Full Text] [Related]
68. Lateral variations of radiobiological properties of therapeutic fields of
Dewey S; Burigo L; Pshenichnov I; Mishustin I; Bleicher M
Phys Med Biol; 2017 Jun; 62(14):5884-5907. PubMed ID: 28557800
[TBL] [Abstract][Full Text] [Related]
69. Monte Carlo simulations of a low energy proton beamline for radiobiological experiments.
Dahle TJ; Rykkelid AM; Stokkevåg CH; Mairani A; Görgen A; Edin NJ; Rørvik E; Fjæra LF; Malinen E; Ytre-Hauge KS
Acta Oncol; 2017 Jun; 56(6):779-786. PubMed ID: 28464743
[TBL] [Abstract][Full Text] [Related]
70. Monte Carlo simulations of ³He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness.
Taleei R; Guan F; Peeler C; Bronk L; Patel D; Mirkovic D; Grosshans DR; Mohan R; Titt U
Med Phys; 2016 Feb; 43(2):761-76. PubMed ID: 26843239
[TBL] [Abstract][Full Text] [Related]
71. Physical and biological factors determining the effective proton range.
Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
Med Phys; 2013 Nov; 40(11):111716. PubMed ID: 24320424
[TBL] [Abstract][Full Text] [Related]
72. Sensitivity of a mini-TEPC to radiation quality variations in clinical proton beams.
Selva A; Bianchi A; Cirrone GAP; Petringa G; Romano F; Schettino G; Conte V
Phys Med; 2024 Feb; 118():103201. PubMed ID: 38199179
[TBL] [Abstract][Full Text] [Related]
73. INVESTIGATING VARIABLE RBE IN A 12C MINIBEAM FIELD WITH MICRODOSIMETRY AND GEANT4.
Debrot E; Bolst D; James B; Tran L; Guatelli S; Petasecca M; Prokopovich DA; Reinhard M; Matsufuji N; Jackson M; Lerch M; Rosenfeld AB
Radiat Prot Dosimetry; 2019 May; 183(1-2):160-166. PubMed ID: 30668821
[TBL] [Abstract][Full Text] [Related]
74. Systematics of relative biological effectiveness measurements for proton radiation along the spread out Bragg peak: experimental validation of the local effect model.
Grün R; Friedrich T; Krämer M; Scholz M
Phys Med Biol; 2017 Feb; 62(3):890-908. PubMed ID: 28072575
[TBL] [Abstract][Full Text] [Related]
75. Effect of Irradiation Time on Biological Effectiveness and Tumor Control Probability in Proton Therapy.
Takei H; Inaniwa T
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):222-229. PubMed ID: 31085286
[TBL] [Abstract][Full Text] [Related]
76. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
Paganetti H
Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
[TBL] [Abstract][Full Text] [Related]
77. Monte Carlo GEANT4-based application for in vivo RBE study using small animals at LNS-INFN preclinical hadrontherapy facility.
Pisciotta P; Cammarata FP; Stefano A; Romano F; Marchese V; Torrisi F; Forte GI; Cella L; Cirrone GAP; Petringa G; Gilardi MC; Cuttone G; Russo G
Phys Med; 2018 Oct; 54():173-178. PubMed ID: 30037452
[TBL] [Abstract][Full Text] [Related]
78. The relative biological effectiveness for carbon, nitrogen, and oxygen ion beams using passive and scanning techniques evaluated with fully 3D silicon microdosimeters.
Tran LT; Bolst D; Guatelli S; Pogossov A; Petasecca M; Lerch MLF; Chartier L; Prokopovich DA; Reinhard MI; Povoli M; Kok A; Perevertaylo VL; Matsufuji N; Kanai T; Jackson M; Rosenfeld AB
Med Phys; 2018 May; 45(5):2299-2308. PubMed ID: 29572856
[TBL] [Abstract][Full Text] [Related]
79. Monte Carlo evaluation of high-gradient magnetically focused planar proton minibeams in a passive nozzle.
McAuley GA; Lim CJ; Teran AV; Slater JD; Wroe AJ
Phys Med Biol; 2022 May; 67(11):. PubMed ID: 35421853
[No Abstract] [Full Text] [Related]
80. Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams.
Loap P; Giorgi M; Vu-Bezin J; Kirov K; Sampai JM; Prezado Y; Kirova Y
Cancer Radiother; 2024 Apr; 28(2):195-201. PubMed ID: 38599941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
